المؤلفون: O'Byrne PM; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada. obyrnep@mcmaster.ca.; Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, 1280 Main Street West, Room 3W10, Hamilton, ON, L8S 4K1, Canada. obyrnep@mcmaster.ca., Jacques L; Respiratory Medicine Development Centre, GSK, London, TW8 9GS, UK., Goldfrad C; Quantitative Sciences Division, GSK, London, TW8 9GS, UK., Kwon N; Respiratory Franchise Medical, GSK, London, TW8 9GS, UK., Perrio M; Global Clinical Safety and Pharmacovigilance, GSK, TW8 9GS, London, UK., Yates LJ; Respiratory Franchise Medical, GSK, London, TW8 9GS, UK., Busse WW; University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

المصدر: Respiratory research [Respir Res] 2016 Nov 24; Vol. 17 (1), pp. 157. Date of Electronic Publication: 2016 Nov 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE

مواضيع طبية MeSH: Androstadienes/*administration & dosage , Anti-Asthmatic Agents/*administration & dosage , Asthma/*drug therapy , Glucocorticoids/*administration & dosage , Lung/*drug effects, Administration, Inhalation ; Androstadienes/adverse effects ; Anti-Asthmatic Agents/adverse effects ; Asthma/diagnosis ; Asthma/physiopathology ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Drug Administration Schedule ; Forced Expiratory Volume ; Glucocorticoids/adverse effects ; Humans ; Lung/physiopathology ; Randomized Controlled Trials as Topic ; Time Factors ; Treatment Outcome

المؤلفون: O'Byrne PM; Firestone Institute for Respiratory Health, and Department of Medicine, McMaster University Medical Centre, 1280 Main Street West, Room 3 W10, Hamilton, ON, L8S 4 K1, Canada. obyrnep@mcmaster.ca., D'Urzo T; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada. tonydurzo@sympatico.ca., Beck E; Institut für Gesundheitsförderung GmbH, Rüdersdorf, Germany. beck@ifg-forschung.de., Fležar M; Hospital Golnik, Clinical Department of Pulmonology and Allergy, Golnik, Slovenia. matjaz.flezar@klinika-golnik.si., Gahlemann M; Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland. martina.gahlemann@boehringer-ingelheim.com., Hart L; Boehringer Ingelheim Canada Ltd, Burlington, ON, Canada. lorna.hart@boehringer-ingelheim.com., Blahova Z; Boehringer Ingelheim RCV GmbH & Co. KG, Vienna, Austria. zuzana.blahova@boehringer-ingelheim.com., Toorawa R; Boehringer Ingelheim Ltd, Bracknell, UK. robert.toorawa.ext@boehringer-ingelheim.com., Beeh KM; insaf Respiratory Research Institute, Wiesbaden, Germany. k.beeh@insaf-wi.de.

المصدر: Respiratory research [Respir Res] 2015 Aug 18; Vol. 16, pp. 97. Date of Electronic Publication: 2015 Aug 18.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE

مواضيع طبية MeSH: Adrenergic beta-2 Receptor Agonists/*administration & dosage , Asthma/*diagnosis , Asthma/*drug therapy , Benzoxazines/*administration & dosage, Administration, Inhalation ; Adult ; Cross-Over Studies ; Dose-Response Relationship, Drug ; Double-Blind Method ; Drug Administration Schedule ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Treatment Outcome

المؤلفون: O'Byrne PM; Michael G DeGroote School of Medicine, Hamilton, ON, Canada. obyrnep@mcmaster.ca., Woodcock A, Bleecker ER, Bateman ED, Lötvall J, Forth R, Medley H, Jacques L, Busse WW

المصدر: Respiratory research [Respir Res] 2014 Aug 11; Vol. 15, pp. 88. Date of Electronic Publication: 2014 Aug 11.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE

مواضيع طبية MeSH: Androstadienes/*administration & dosage , Androstadienes/*adverse effects , Asthma/*diagnosis , Asthma/*drug therapy, Administration, Inhalation ; Adolescent ; Adult ; Aged ; Asthma/physiopathology ; Child ; Double-Blind Method ; Drug Administration Schedule ; Female ; Forced Expiratory Volume/drug effects ; Forced Expiratory Volume/physiology ; Humans ; Male ; Middle Aged ; Treatment Outcome ; Young Adult

المؤلفون: Gauvreau GM; Department of Medicine, McMaster University, Hamilton, Ontario, Canada. gauvreau@mcmaster.ca, Boulet LP, Schmid-Wirlitsch C, Côté J, Duong M, Killian KJ, Milot J, Deschesnes F, Strinich T, Watson RM, Bredenbröker D, O'Byrne PM

المصدر: Respiratory research [Respir Res] 2011 Oct 26; Vol. 12, pp. 140. Date of Electronic Publication: 2011 Oct 26.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE

مواضيع طبية MeSH: Allergens/*toxicity , Aminopyridines/*therapeutic use , Asthma/*immunology , Asthma/*pathology , Benzamides/*therapeutic use , Phosphodiesterase 4 Inhibitors/*therapeutic use , Pneumonia/*immunology , Pneumonia/*pathology, Adolescent ; Adult ; Asthma/drug therapy ; Cross-Over Studies ; Cyclopropanes/therapeutic use ; Double-Blind Method ; Female ; Forced Expiratory Volume/drug effects ; Forced Expiratory Volume/immunology ; Humans ; Male ; Middle Aged ; Pneumonia/drug therapy ; Pulmonary Eosinophilia/chemically induced ; Pulmonary Eosinophilia/immunology ; Pulmonary Eosinophilia/pathology ; Young Adult

المؤلفون: Bateman ED; Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa. Eric.Bateman@uct.ac.za, Harrison TW, Quirce S, Reddel HK, Buhl R, Humbert M, Jenkins CR, Peterson S, Ostlund O, O'Byrne PM, Sears MR, Eriksson GS

المصدر: Respiratory research [Respir Res] 2011 Apr 04; Vol. 12, pp. 38. Date of Electronic Publication: 2011 Apr 04.

نوع المنشور: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE

مواضيع طبية MeSH: Adrenal Cortex Hormones/*administration & dosage , Adrenergic beta-2 Receptor Agonists/*administration & dosage , Asthma/*drug therapy , Bronchodilator Agents/*administration & dosage , Budesonide/*administration & dosage , Ethanolamines/*administration & dosage , Glucocorticoids/*administration & dosage , Lung/*drug effects, Administration, Inhalation ; Adult ; Analysis of Variance ; Asthma/physiopathology ; Budesonide, Formoterol Fumarate Drug Combination ; Drug Combinations ; Female ; Forced Expiratory Volume ; Formoterol Fumarate ; Humans ; Kaplan-Meier Estimate ; Logistic Models ; Lung/physiopathology ; Male ; Nebulizers and Vaporizers ; Odds Ratio ; Patient Selection ; Practice Guidelines as Topic ; Proportional Hazards Models ; Randomized Controlled Trials as Topic ; Retrospective Studies ; Time Factors ; Treatment Outcome